Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShare-based Compensation (IS)Share-based Compensation (IS)Shares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Depreciation ExpenseEBIATLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares IssuedShares OutstandingShares OutstandingShort-Term Debt repayments
Ratios

Purple Biotech (PPBT) Shares Outstanding (2018 - 2025)

Purple Biotech has reported Shares Outstanding over the past 5 years, most recently at $184.8 million for Q4 2022.

  • Quarterly Shares Outstanding rose 3.83% to $184.8 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $184.8 million through Dec 2022, up 3.83% year-over-year, with the annual reading at $184.8 million for FY2022, 3.83% up from the prior year.
  • Shares Outstanding was $184.8 million for Q4 2022 at Purple Biotech, up from $178.0 million in the prior quarter.
  • Over five years, Shares Outstanding peaked at $184.8 million in Q4 2022 and troughed at $16.0 million in Q4 2018.
  • The 5-year median for Shares Outstanding is $19.6 million (2019), against an average of $83.1 million.
  • Year-over-year, Shares Outstanding fell 12.03% in 2020 and then skyrocketed 934.25% in 2021.
  • A 5-year view of Shares Outstanding shows it stood at $16.0 million in 2018, then increased by 22.21% to $19.6 million in 2019, then dropped by 12.03% to $17.2 million in 2020, then skyrocketed by 934.25% to $178.0 million in 2021, then increased by 3.83% to $184.8 million in 2022.
  • Per Business Quant, the three most recent readings for PPBT's Shares Outstanding are $184.8 million (Q4 2022), $178.0 million (Q4 2021), and $17.2 million (Q4 2020).